BRAF-Mutant Melanoma

Weber Compares BRAF/MEK, Immunotherapy Combos in Melanoma

July 16, 2016

Clinical Articles

With 2 different BRAF/MEK combination regimens approved by the FDA, as well as an immunotherapy combination, treatment and sequencing decisions for metastatic BRAF-mutated melanoma can be difficult.

Combination Regimens for Metastatic Melanoma

May 25, 2016

Clinical Articles

A number of new combination approaches have gained approval in the past year for the treatment of patients with BRAF-mutant metastatic melanoma, expanding the number of effective treatment options that can improve quality and length of life for many patients.

Treatment Sequencing Considerations for BRAF-Mutant Melanoma

May 26, 2016

Clinical Articles

With expanding availability of effective single-agent and combination immunotherapies and combination BRAF/MEK inhibitor regimens, all of which have been shown to improve survival and reduce risk of progression, the optimal sequencing of therapies has become increasingly complex.